IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
Kattner, Anna-Sophia
, Holler, Ernst, Holler, Barbara, Klobuch, Sebastian , Weber, Daniela, Martinovic, Danilo, Edinger, Matthias, Herr, Wolfgang and Wolff, Daniel
(2020)
IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Annals of Hematology 99 (4), pp. 847-853.
Date of publication of this fulltext: 11 Oct 2021 13:01
Article
 | There is a more recent version of this item available. |
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Annals of Hematology | ||||
| Publisher: | Springer | ||||
|---|---|---|---|---|---|
| Place of Publication: | NEW YORK | ||||
| Volume: | 99 | ||||
| Number of Issue or Book Chapter: | 4 | ||||
| Page Range: | pp. 847-853 | ||||
| Date | 2020 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; INTERLEUKIN-6; RESPONSES; CRITERIA; Allogeneic hematopoietic stem cell transplantation; Chronic graft-versus-host disease; Tocilizumab; Interleukin-6 | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 50294 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric